These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25035553)
1. Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications. Karthik MS; Warikoo N; Chakrabarti S; Grover S; Kulhara P Indian J Psychol Med; 2014 Jul; 36(3):288-93. PubMed ID: 25035553 [TBL] [Abstract][Full Text] [Related]
2. Attitude towards second-generation antipsychotics among patients with schizophrenia and their relatives. Karthik MS; Kulhara P; Chakrabarti S Hum Psychopharmacol; 2013 Sep; 28(5):457-65. PubMed ID: 23784674 [TBL] [Abstract][Full Text] [Related]
3. Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries. Barbui C; Nosè M; Mazzi MA; Bindman J; Leese M; Schene A; Becker T; Angermeyer MC; Koeter M; Gray R; Tansella M Int Clin Psychopharmacol; 2006 Mar; 21(2):73-9. PubMed ID: 16421457 [TBL] [Abstract][Full Text] [Related]
4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
5. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. Freudenreich O; Cather C; Evins AE; Henderson DC; Goff DC J Clin Psychiatry; 2004 Oct; 65(10):1372-6. PubMed ID: 15491241 [TBL] [Abstract][Full Text] [Related]
6. Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009). Xiang YT; Kreyenbuhl J; Dickerson FB; Ungvari GS; Wang CY; Si TM; Lee EH; He YL; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N Aust N Z J Psychiatry; 2012 Dec; 46(12):1159-64. PubMed ID: 22790175 [TBL] [Abstract][Full Text] [Related]
7. Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study. Chen VC; Liao YT; Lai TJ; Lane HY; Shao WC; Dewey M; Lee CT; Lu ML Schizophr Res; 2015 Dec; 169(1-3):406-411. PubMed ID: 26481616 [TBL] [Abstract][Full Text] [Related]
8. Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia. Warikoo N; Chakrabarti S; Grover S Indian J Psychol Med; 2014 Jan; 36(1):33-9. PubMed ID: 24701007 [TBL] [Abstract][Full Text] [Related]
9. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Volavka J; Citrome L Expert Opin Pharmacother; 2009 Aug; 10(12):1917-28. PubMed ID: 19558339 [TBL] [Abstract][Full Text] [Related]
10. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Kishimoto T; Agarwal V; Kishi T; Leucht S; Kane JM; Correll CU Mol Psychiatry; 2013 Jan; 18(1):53-66. PubMed ID: 22124274 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Olanzapine versus Other Second-Generation Antipsychotics in the Improvement of Insight and Medication Discontinuation Rate in Schizophrenia. He H; Zhou Y; Yang M; Li X; Xiang YT; Luo J Shanghai Arch Psychiatry; 2018 Jun; 30(3):178-187. PubMed ID: 30858669 [TBL] [Abstract][Full Text] [Related]
12. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. Naber D; Lambert M CNS Drugs; 2009 Aug; 23(8):649-59. PubMed ID: 19594194 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the efficacy of second-generation antipsychotics. Davis JM; Chen N; Glick ID Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218 [TBL] [Abstract][Full Text] [Related]
14. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Gründer G; Heinze M; Cordes J; Mühlbauer B; Juckel G; Schulz C; Rüther E; Timm J; Lancet Psychiatry; 2016 Aug; 3(8):717-729. PubMed ID: 27265548 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS score. Pilla Reddy V; Kozielska M; Suleiman AA; Johnson M; Vermeulen A; Liu J; de Greef R; Groothuis GM; Danhof M; Proost JH Schizophr Res; 2013 May; 146(1-3):153-61. PubMed ID: 23473811 [TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics. Adam UU; Husain N; Haddad PM; Munshi T; Tariq F; Naeem F; Chaudhry IB Neuropsychiatr Dis Treat; 2014; 10():1953-9. PubMed ID: 25342903 [TBL] [Abstract][Full Text] [Related]
18. 'Real world' comparison of first- and second-generation antipsychotics in regard to length of inpatient hospitalization and number of re-hospitalizations. Advokat C; Hill BD; Comaty JE Psychiatr Q; 2008 Mar; 79(1):55-64. PubMed ID: 18060498 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Zhang JP; Gallego JA; Robinson DG; Malhotra AK; Kane JM; Correll CU Int J Neuropsychopharmacol; 2013 Jul; 16(6):1205-18. PubMed ID: 23199972 [TBL] [Abstract][Full Text] [Related]
20. Change in antipsychotic usage pattern and risk of relapse in older patients with schizophrenia. Talaslahti T; Alanen HM; Hakko H; Isohanni M; Häkkinen U; Leinonen E Int J Geriatr Psychiatry; 2013 Dec; 28(12):1305-11. PubMed ID: 23558986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]